FDA Launches Probe into Potential Link Between COVID-19 Vaccines and Deaths Across Age Groups

December 10, 2025

WASHINGTON – The U.S. Food and Drug Administration (FDA) has opened a comprehensive investigation into potential links between COVID-19 vaccines and deaths across multiple age groups, federal health officials confirmed Tuesday. The probe, which initially focused on pediatric cases, has now been expanded to include adults, signaling a major shift in the agency’s approach to vaccine safety monitoring under the current administration.

The investigation comes amidst a firestorm of controversy following a leaked internal memo from a top FDA official claiming that COVID-19 vaccinations caused the deaths of at least 10 children—a conclusion that has drawn sharp rebuke from independent medical experts and former agency leaders who warn the claims lack scientific rigor.

Expanded Scope of Inquiry

The Department of Health and Human Services (HHS) confirmed the widening scope of the review on Tuesday. “FDA is doing a thorough investigation, across multiple age groups, of deaths potentially related to coronavirus vaccines,” said Andrew Nixon, a spokesman for the HHS, in a statement to the press.

The probe aims to re-examine adverse event reports that were previously reviewed by agency staff. While the specific methodology of the new investigation has not been fully detailed, officials indicate it will involve a “more rigorous” scrutiny of data from the Vaccine Adverse Event Reporting System (VAERS) and other safety databases.

The Controversy: Internal Memo Sparks Debate

The impetus for the expanded probe appears to be an internal email sent late last month by Dr. Vinay Prasad, the recently appointed Director of the FDA’s Center for Biologics Evaluation and Research (CBER). In the memo, Dr. Prasad asserted that a review of available data led agency staff to conclude that “at least 10 children have died after and because of receiving COVID-19 vaccination.”

According to reports, the memo cited cases of children aged 7 to 16 involving myocarditis—a rare inflammation of the heart muscle known to be a potential side effect of mRNA vaccines, though typically mild and treatable. Dr. Prasad’s directive suggests a departure from previous safety assessments, which had determined that the benefits of vaccination in preventing severe COVID-19 outcomes far outweighed the rare risks.

“This is a profound revelation,” Dr. Prasad wrote in the leaked communication. “For the first time, the US FDA will acknowledge that COVID-19 vaccines have killed American children.”

Expert Backlash and Scientific Skepticism

The claims have been met with immediate and intense skepticism from the broader medical community. Infectious disease experts point out that the data source cited—VAERS—is a passive reporting system that accepts submissions from anyone, including the public, and cannot by itself establish causality.

“When you make that kind of sensational claim, it is incumbent upon you to provide evidence that supports that claim. He didn’t supply any evidence,” said Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia and a former member of the FDA’s vaccine advisory committee.

Critics argue that attributing deaths solely to the vaccine based on temporal proximity (occurring shortly after the shot) ignores other potential causes and contradicts peer-reviewed studies involving millions of doses.

“We have not seen the science to confirm this,” stated Dr. Anna Durbin, a vaccine researcher at Johns Hopkins Bloomberg School of Public Health. “Saying definitively that a vaccine caused a death requires careful assessment, best done with an autopsy examination, and ruling out other causes of death.”

In a rare unified front, a dozen former FDA commissioners published a perspective in the New England Journal of Medicine (NEJM) earlier this week, warning that the new leadership’s approach could “undermine the nation’s ability to fight infectious diseases” and “threaten the health of vulnerable Americans.”

Regulatory Implications

Beyond the investigation into deaths, the FDA is signaling a pivot in how it approves new vaccines. Dr. Prasad has proposed requiring pharmaceutical companies to conduct large-scale randomized trials demonstrating that new vaccines prevent clinical disease outcomes—rather than just generating an immune response—before they reach the market.

While proponents argue this will ensure higher safety and efficacy standards, industry analysts and health experts worry it could significantly delay access to updated vaccines during rapidly evolving outbreaks.

Public Health Impact

Public health officials are concerned that the investigation and the authoritative tone of the internal memo may deepen vaccine hesitancy. With confidence in routine childhood immunizations already fragile, the fear is that unverified claims from high-ranking officials could lead to a drop in vaccination rates for other preventable diseases like measles and polio.

“The FDA memo may provide what appears to be official validation for parental concerns about vaccine safety,” noted a policy brief from KFF (formerly the Kaiser Family Foundation). “When federal health officials frame unverified reports as evidence… it becomes difficult to explain the system’s limitations.”

What This Means for You

For the general public, the announcement of this probe introduces new questions but does not change current clinical recommendations from major medical societies. As of now, the Centers for Disease Control and Prevention (CDC) continues to recommend COVID-19 vaccination for all eligible individuals aged 6 months and older, emphasizing that severe adverse events remain rare.

Healthcare providers are advised to continue monitoring for potential side effects, including myocarditis, particularly in adolescent males, while discussing the benefit-risk profile with patients.

“We must follow the evidence where it leads,” said an FDA spokesperson. “But that evidence must be rigorous, peer-reviewed, and reproducible.”

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References:

• Reuters: “FDA probes possible link between COVID vaccines and related deaths across age groups.” (December 9, 2025).